Funding Opportunities
Project Title: Johns Hopkins-Allegheny Health Network Cancer Research Fund
Sponsoring Department: Oncology
Deadline Date: Monday, November 19, 2018

Dear Colleagues:

The Johns Hopkins University School of Medicine announces the fifth annual request for applications (RFA) for the Hopkins-Allegheny Health Network (AHN) Cancer Research Fund. Hopkins-AHN Awards will fund cancer research projects at the level of $100,000 direct costs per year, with an award term of two years

The expectation is that Hopkins-AHN Awards will spark synergistic interactions among investigators and catalyze scientific achievements of the highest quality and impact. Applications are welcomed from across the spectrum of fundamental, translational, clinical, and epidemiologic research. Applications are similarly free to focus on specific organ sites or on issues that span multiple cancer types. Applications will be evaluated by reviewers from both the Sidney Kimmel Comprehensive Cancer Center (SKCCC) and the Allegheny Health Network Cancer Institute (AHN CI) and review will be based on their potential to influence our scientific understanding of cancer and our clinical, operational, and financial management of the disease.

Timing: Applications are due by November 15th, 2018. Awards will be announced in February for funding beginning April 1. It is expected that up to 10 Awards will be made this cycle.
Applications will be submitted through:

Each proposal must include a SKCCC Member or AHN researcher as principal investigator (PI) or co-principal investigator (Co-PI). A SKCCC Member or AHN researcher may only participate in one application as PI or Co-PI. The proposal cannot be duplicative with other funding, at the time of the award. Overlap will be assessed by SKCCC staff on a Just-In-Time model. Applications including both SKCCC and AHN researchers will be favorably received, as will applications that have the potential to bring new approaches and expertise to bear on important problems in cancer research.

Applications will be submitted online and will consist of:
1. Coversheet, which will be downloaded from this site.
2. A research proposal of 2 pages or less, including figures but not references (separate page).

  1. Specific Aims
  2. Significance
  3. Background, including preliminary studies of the applicant
  4. Research Design, including potential impact if successful

3. A one page budget and budget justification that describes how the funding will be allocated among personnel, supplies, and equipment. Faculty salary can be included or excluded. Budgets up to $100,000 direct costs per year can be proposed. No indirect costs can be included.
4. An NIH-style biosketch (5 pages maximum) for the PI and Co-PIs (if applicable). It is not necessary to include current or pending funding information, as these will be requested Just In Time.

Review Process: Applications will be subjected to two-tiered review in the SKCCC. Applications will first undergo numerical scoring by at least two reviewers. Neither comments nor scores will be returned to applicants. Applications will then be ranked in order of priority of funding by senior members of the SKCCC. Final funding decisions will be made by a research council composed of both SKCCC and AHN researchers.

Post-Award Requirements 
Recipients must complete an interim and final progress report and provide information on publications, reports of invention and external funding applications enabled by this award. Approval of the second year of funding is contingent on receipt of the interim report.


Samuel R. Denmeade, M.D.
Departments of Oncology, Pharmacology and Molecular Sciences, and Biomedical Engineering
School of Medicine
Johns Hopkins University

Andrew J. Ewald, Ph.D.
Associate Professor
Departments of Cell Biology, Oncology, and Biomedical Engineering
School of Medicine
Johns Hopkins University

Phuoc T. Tran, M.D., Ph.D.
Associate Professor
Departments of Radiation Oncology & Molecular Radiation Sciences and Oncology
School of Medicine
Johns Hopkins University

For More Information and Questions:
Deirdre Salanger